Nuveen, LLC Royalty Pharma PLC Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Nuveen, LLC holds 891,378 shares of RPRX stock, worth $29.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
891,378Holding current value
$29.7 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
460Shares Held
299MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.32 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.22 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$768 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$566 Million0.79% of portfolio
-
Baillie Gifford & CO13.4MShares$447 Million0.38% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.6B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...